Life Sciences

BoxGroup

Check: BoxGroup currently publishes a firm-wide maximum investment of $1M. Historical sources reported smaller firm checks and third-party profiles estimate $250K–$750K for Nimi, but no primary source confirms a current personal range.

Nimi is a generalist early-stage Partner with a long-running, publicly documented focus on healthcare and life sciences, fintech, marketplaces, and software. Her current activity extends that lens into AI-native healthcare, scientific agents, enterprise AI, and the financial infrastructure surrounding AI use. She applies BoxGroup's founder-first philosophy while testing whether the operating model, retention, sequencing, and economics can support the founder's category-scale ambition.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Hans Hekland is listed in a Associate Advisor capacity at Sarsia. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Erlend Skagseth invests or supports investment decisions through Sarsia's published strategy: Build early Norwegian science and technology companies in life science, energy and sustainability through specialist capital and active ownership.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Øivind Enger is listed in a Operating Partner capacity at Sarsia. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Marit Wick is listed in a Advisor, Finance capacity at Sarsia. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Olav Skjervheim is listed in a Compliance capacity at Sarsia. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Maija Slaidiņa invests or supports investment decisions through Sarsia's published strategy: Build early Norwegian science and technology companies in life science, energy and sustainability through specialist capital and active ownership.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Jon-Kåre Hansen invests or supports investment decisions through Sarsia's published strategy: Build early Norwegian science and technology companies in life science, energy and sustainability through specialist capital and active ownership.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Farzad Abdi-Dezfuli invests or supports investment decisions through Sarsia's published strategy: Build early Norwegian science and technology companies in life science, energy and sustainability through specialist capital and active ownership.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Henrik Solberg-Johansen invests or supports investment decisions through Sarsia's published strategy: Build early Norwegian science and technology companies in life science, energy and sustainability through specialist capital and active ownership.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Hilde Holdhus invests or supports investment decisions through Sarsia's published strategy: Build early Norwegian science and technology companies in life science, energy and sustainability through specialist capital and active ownership.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Jon Trygve Berg invests or supports investment decisions through Sarsia's published strategy: Build early Norwegian science and technology companies in life science, energy and sustainability through specialist capital and active ownership.

Sarsia

Check: NOK 2M-NOK 5M in a first round and up to NOK 30M-NOK 40M over time, as published by Sarsia.

Sveinung Hole invests or supports investment decisions through Sarsia's published strategy: Build early Norwegian science and technology companies in life science, energy and sustainability through specialist capital and active ownership.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Reinhard Krickl invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Nora Kaarela invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Florian Eckhardt is listed in a Senior Advisor capacity at Hadean Ventures. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Lene Gerlach invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Lene Dragesund is listed in a Senior Office Manager capacity at Hadean Ventures. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Pål R. Jensen is listed in a Senior Advisor Operations capacity at Hadean Ventures. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Silje C. L. Ervik is listed in a Head of Legal capacity at Hadean Ventures. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Vilde Fredheim is listed in a Director, Investor Relations & Business Development capacity at Hadean Ventures. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Paal August Nordhagen is listed in a Director of Finance & Controlling capacity at Hadean Ventures. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Camilla Olsen is listed in a Impact & ESG Manager capacity at Hadean Ventures. The profile preserves that non-investment or undisclosed-role distinction and uses the firm's mandate only as shared context.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Markèta Chlubnovà invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Yun Yang invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Markus Dietrich invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Miao He invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Georgina Askeland invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Roger Franklin invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Walter Stockinger invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Hadean Ventures

Check: Hadean Ventures does not publish a standard current check-size range on its official website.

Ingrid Teigland Akay invests or supports investment decisions through Hadean Ventures's published strategy: Back science-driven European healthcare companies with the potential to improve patient outcomes and create durable value.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Olga Ziessen is listed in a Head Support Services capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Philippe van Santen is listed in a Facility Manager capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Chelle Tjabring invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Marijana Stojanovic is listed in a Receptionist capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Tess Keg invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Britt Inga Emerson is listed in a Senior Executive Assistant, Investor Relations (US) capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Tineke Duijn is listed in a Office Assistant capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Dragana Dragusin invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Alicia Dortona is listed in a Office Manager capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Danielle de Magalhães invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Rachelle Young is listed in a Investor Relations Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Maureen Wouters is listed in a Paralegal capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Patricia Vonk invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Viktorija Vodilovska is listed in a AI Specialist capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Iris Veldman is listed in a Deal Counsel capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Pascal van Wees is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Thijs van Egmond is listed in a Legal Counsel capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Devan Sequeira is listed in a IT Solution Architect capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Walter Schram is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Francine MacLeod invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Stijn Jochemsen is listed in a Finance Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Marnix Groot is listed in a Fund Controller capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Baris Duvan is listed in a Senior Paralegal capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Bart de Jong is listed in a Finance Manager capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Vincent Conijn is listed in a Senior Associate, Impact & ESG capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Lior Alperovich is listed in a Marketing & Communications Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Joost de Rijk is listed in a Investor Relations Director capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Marc van Voorst tot Voorst is listed in a Head of Public Affairs capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Arjan Oosterheert is listed in a Head of Tax capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Cyril Lesser is listed in a Vice President Finance - Funds capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Jennifer Fritzsche is listed in a Vice President Finance capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Silva Dezelan is listed in a Head of Impact and ESG capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Laura Asbjornsen is listed in a Head of Marketing & Communications capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Alice Vickers is listed in a Venture Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Feike Sijbesma is listed in a Senior Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Floor Saris is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Liz Rodgers is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Steen Riisgaard is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Holger Reithinger is listed in a Senior Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Stefan Oschmann is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

An Michiels is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Frank G. Holz is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Scott Friedman is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

John Ford is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Simon J Clark is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Michael Burgess is listed in a Advisor capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Jens Wendland invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Patrick Vink invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Onno van de Stolpe invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Patrick Round invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Yigal M. Pinto invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Jonathan McNeill invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Gökben Koca invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Michael Hayden invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Cees de Jong invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Matt Cooper invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Josh Brumm invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Philip Astley-Sparke invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Sander van Deventer is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Gijs van den Brink is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

John Montana is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

John McDonald is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Ton Logtenberg is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

John J.P. Kastelein is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Carlo Incerti is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Peter Høngaard Andersen is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Rory Gummerson is listed in a Operating Partner, Talent Acquisition capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Check: Forbion does not publish one standard current check-size range across its funds on the official site.

Per Falholt is listed in a Operating Partner capacity at Forbion. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.

Forbion

Naarden, Netherlands

Cambridge Innovation Capital

Cambridge, United Kingdom

Inveready

Barcelona, Spain

Bayern Kapital

Landshut, Bavaria, Germany

Anzu Partners

Boston / San Diego / Tampa / Washington, DC / Atlanta

AUM: Approximately $1B

Portugal Ventures

Porto and Lisbon, Portugal

Elaia

Paris, France

Seventure Partners

Paris, France

Investinor

Trondheim, Norway

PSV

Kongens Lyngby, Denmark

Cultivation Capital

St. Louis, Missouri

Innovestor

Helsinki, Finland

Industrifonden

Stockholm, Sweden

Parkwalk Advisors

London, United Kingdom

M Ventures

Amsterdam, Netherlands

Wellington Partners

Munich, Germany

DeepTech & Climate Fonds

Berlin, Bonn and Munich, Germany

Elevate Ventures

Indianapolis, Indiana

Innovation Industries

Amsterdam, Netherlands

NRW.Venture

Düsseldorf, Germany

BioGeneration Ventures

Naarden, Netherlands

Hadean Ventures

Oslo, Norway and Stockholm, Sweden

Mercia Ventures

United Kingdom

Michigan Capital Network

Grand Rapids, Michigan

Vi Partners

Switzerland

Newton Biocapital

Brussels, Belgium and Tokyo, Japan

Safar Partners

Cambridge, Massachusetts

Brandenburg Kapital

Potsdam, Germany

Claris Ventures

Turin, Italy

Panakès Partners

Milan, Italy

Clarevia

Madison, Wisconsin

Sandwater

Oslo, Norway

redalpine

Zurich, Switzerland

Sarsia

Bergen, Norway

Navigare Ventures

Stockholm, Sweden

R1 Capital

Columbus, Ohio

Heal Capital

Berlin, Germany

Michigan Rise

East Lansing, Michigan

XISTA Science Ventures

Vienna, Austria

CincyTech

Cincinnati, Ohio

Metavallon VC

Athens, Greece

Civilization Ventures

San Francisco, California

Thuja Capital

Utrecht, Netherlands

i&i Bio

Prague, Czechia

MassVentures

Waltham, Massachusetts / Worcester, Massachusetts

Practica Capital

Vilnius, Lithuania

Nordic Science Investments

Helsinki, Finland

DeepWork Capital

Orlando, Florida

Good Growth Capital

Charleston, South Carolina

V-Bio Ventures

Ghent, Belgium

Voima Ventures

Helsinki, Finland

Kickfund

Basel, Switzerland

Vesalius Biocapital

Luxembourg

OCCIDENT

Munich, Germany and Zug, Switzerland

Okapi Venture Capital

Newport Beach, California

Zetta Venture Partners

San Francisco, California

Possible Ventures

Munich, Germany

INITIATE Ventures

United States